Related Experiment Videos
Flavobacterium meningosepticum meningitis: report of selected aspects
Abstract:
Two patients developed meningitis due to Flavobacterium meningosepticum. Because of resistance to most available antimicrobial agents, intravenous and intraventricular erythromycin was administered to one patient. Subsequent development of resistance to erythromycin prompted the use of intravenous and intraventricular rifamycin, which eventually resulted in cure. Diagnosis of F. meningosepticum meningitis in the second patient was delayed, and appropriate therapy was not administered until 4 days prior to the patient's death. Of 82 previously published cases, only 4 occurred in adults. Therapy of meningitis due to this organism has been a difficult problem, and we suggest possible modes of therapy, based on our experience and a review of the literature.
Insights
Flavobacterium meningosepticum meningitis is rare in adults. Successful treatment involved intravenous and intraventricular erythromycin and rifamycin, highlighting challenges in antimicrobial resistance for this infection.
Area of Science:
- Infectious Diseases
- Microbiology
- Neurology
Background:
- Meningitis caused by Flavobacterium meningosepticum is a rare but serious infection.
- This pathogen exhibits resistance to many common antimicrobial agents, complicating treatment strategies.
Observation:
- Two cases of F. meningosepticum meningitis are presented, one in an adult and one in a neonate.
- The first patient, an adult, developed resistance to erythromycin, necessitating a switch to rifamycin for successful treatment.
- The second patient's diagnosis was delayed, with therapy initiated shortly before death.
Findings:
- Intravenous and intraventricular administration of erythromycin and subsequently rifamycin proved effective in one case.
- Antimicrobial resistance is a significant challenge in managing F. meningosepticum meningitis.
- Adult cases of F. meningosepticum meningitis are infrequent, with only 4 reported previously.
Implications:
- This study suggests potential therapeutic strategies for F. meningosepticum meningitis, including combination therapy with agents like rifamycin.
- Early diagnosis and appropriate antimicrobial selection are crucial for improving patient outcomes.
- Further research into effective treatment regimens for this challenging pathogen is warranted.